Kimberly-Clark bets $40 billion on Kenvue
Digest more
The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...
Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits ...
Kenvue (KVUE) reported a net profit margin of 9.4%, up from 7.3% last year. One-year earnings growth reached 26.3%, and the ...
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.
Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings ...
D.E. Shaw, one of the Tylenol-maker’s largest shareholders, stood to lose over $200 million but is now expected to break even ...
Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback